This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A Second View: Discussing the FDA Approval of Oluminant for treatment of Alopecia Areata
Ticker(s): LLY, INCYWho's the expert?
Institution: Ada West Dermatology
- Authored of more than 60 papers on clinical interests that include psoriasis, acne, melanoma, tropical dermatology, and photosensitive skin disorders.
- Collaborated on several presentations of dermatological research at conferences
- Manages 30 patients with alopecia areata
- Plans on prescribing oluminant
Interview GoalTo discuss the recent FDA approval of Oluminant and the standard of care for alopecia areata
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
